Physician profile
Kamel Ben Othmane
NPI 1316966328
$1,737.37
in general payments reported to CMS, 2019-2025
12 companies · $454 in 2025
The $454 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $132 · 2021: $182 · 2022: $69.50 · 2023: $156 · 2024: $391 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.70 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $802.70 | 2019-2025 | Vumerity, Tysabri |
| Allergan, INC. | $199.31 | 2019-2021 | |
| Pfizer INC. | $191.73 | 2024-2025 | |
| Ceribell, INC. | $183.55 | 2025 | Pocket Eeg Device |
| Teva Pharmaceuticals USA, INC. | $99.00 | 2024 | |
| Lundbeck LLC | $95.44 | 2019-2025 | Vyepti |
| Abbvie INC. | $56.10 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $33.62 | 2021-2024 | |
| Tg Therapeutics, INC. | $23.11 | 2023 | |
| Alexion Pharmaceuticals, INC. | $21.61 | 2019 | |
| Emd Serono, INC. | $19.47 | 2025 | |
| Livanova USA, INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamel Ben Othmane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.